Skip to main content

DBV Technologies S.A.

DBVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001613780

In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesDBVTF

Q4 2023 vs. Q3 2023

How the institutions holding DBV Technologies S.A. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of DBVT: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3840+2
Shares44.4M37.7M−6.69M (−15.1%)
Value$60.4M$35.9M−$24.5M (−40.5%)

New holders (9)

Institutions that held DBV Technologies S.A. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to DBVT in Q4 2023
InstitutionSharesValue% of portfolio
HRT Financial LP151,985$144.0K0.00%
Jane Street Group, LLC59,307$56.5K0.00%
Cowen and Company, LLC50,986$48.6K0.00%
CoreCap Advisors, LLC13,478$12.8K0.00%
Old Mission Capital LLC13,379$12.7K0.00%
Virtu Financial LLC12,555$12.0K0.00%
JGP Global Gestao de Recursos Ltda.11,658$11.1K0.01%
Susquehanna International Group, LLP10,671$10.2K0.00%
Advisory Services Network, LLC1,300$1.24K0.00%

Sold out (7)

Institutions that held DBV Technologies S.A. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of DBVT in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Fairmount Funds Management LLC6,781,150$9.22M
BlackRock Inc.915,341$1.24M
Optiver Holding B.V.274,874$373.8K
Lynx1 Capital Management LP18,265$24.8K
XTX Topco Ltd14,426$19.6K
Heritage Wealth Advisors6,000$8.16K
Cubist Systematic Strategies, LLC2,707$3.68K